The Healthcare Innovator and former Accenture executive brings deep industry relationships and advances Dario's AI-driven chronic care platform.
new york, February 27, 2025 /PRNewswire/ -DarioHealth Corp. (NASDAQ: DRIO) (“Dario” or “Company”), the leader in AI-driven digital health solutions, today said. Lawrence (Larry) B. leisure He brought 40 years of healthcare leadership, managed care expertise and digital health innovation to the company's governance. Combined with Mr. Leisure's extensive experience working with health plans, health systems, consultants and employer coalitions, and a deep understanding of health policies, reimbursements, and value-based care models, it helps to guide Dario's continued expansion in the payer and employer market.
Leisure said that Towers Perin (also known as Willis Towers Watson) Next, move to management consulting first as a senior partner at Pricewaterhousecoopers and later as a managing partner at Accenture. He served as senior leadership roles in the Kaiser Foundation Health Plan and the Optuminsight units of the UnitedHealth Group. His pivot on investment in healthcare began with joining his venture capital firm Kleiner Perkins As an operating partner. In 2014, he co-founded Chicago Pacific Founders, a private equity company focusing on healthcare.
As an avid advocate for healthcare innovation, Leisure co-founded the Employer Health Innovation Roundtable, a coalition representing the lives of more than 6 million people. Mr. Leisure is chairman of UCSF Rosenman Institute, a member of the UCLA Anderson Management Advisor Committee, and a senior advisor at the Mussalem Biodecigoo Center. Stanford University.
He received his bachelor's degree in economics Stanford University His MBA from UCLA Anderson Management School. He lives Atherton, California With his wife, Bren.
“We are honored to welcome Larry to Dario's board of directors,” he said. Erez RaphaelCEO of Dario. “His deep expertise across the healthcare ecosystem from payers, employer groups and healthcare innovators provides invaluable insights as we continue to expand our solutions and strengthen our value-based partnerships.
About Dariohealth Corp.
Dariohealth Corp. (NASDAQ: DRIO) is a leading digital health company that revolutionizes the way people with chronic illnesses manage their health through a user-centered, multi-chronic digital therapy platform. Dario's platform and set of solutions provide personalized, dynamic interventions driven by data analysis and one-to-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health.
Dario's user-centric platform provides people with continuous, customized care for their health, disrupting traditional episodic approaches to health care. This approach allows people to adapt their lifestyles overall for sustainable behavioral change, promote exceptional user satisfaction, retention and outcomes, and do the right thing to do simple things.
Dario offers highly user-rated solutions worldwide for health plans and other payers, self-insured employers, care providers and consumers. For more information about Dario and its digital health solutions, visit http://dariohealth.com.
Caution regarding forward-looking statements
This news release and statements from representatives and partners of Dariohealth Corp. may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or may include forward-looking lawsuits. For example, the company uses forward-looking statements in this press release when discussing its belief that adding Mr. Leisure as a member of the board will guide Dario's continued expansion within the payer and employer markets and help advance Dario's AI-driven chronic care platform. Without limiting the generality above, words such as “plan”, “project”, “possibility”, “seek”, “may”, “will”, “imagination”, “believe”, “intention”, “possibility”, “estimation” are intended to identify a moving forward statement. Readers should note that certain important factors may affect the company's actual outcomes and may differ materially from forward-looking statements that may be made in this news release. Factors that may affect our outcomes include, but are not limited to, regulatory approval, product demand, market acceptance, the impact of competitive products and prices, product development, commercialization or technical difficulties, success or failure in negotiations and trade and trade, legal, social and economic risks, and risks related to the adequacy of existing cash resources. Additional factors that may cause or contribute to differences between our actual results and forward-looking statements include, but are not limited to, risks discussed in the company's filing with the Securities and Exchange Commission. Readers should note that actual results (the timing and results of the DARIO™ company's commercial and regulatory plans described herein) may differ materially from those stated in the forward-looking statements. We have no obligation to publish forward-looking statements as new information, future events, or other consequences, except as required by applicable law.
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
(Email protection)
+1-312-593-4280
Contact for DarioHealth Investor Relations
Cat Parera
Investor Relations Manager
(Email protection)
+315-378-6922
Logo: https://mma.prnewswire.com/media/1920436/3708722/dariohealth_logo.jpg
Source: Dariohealth Corp.
